drugset

drugset / Trial / NCT00002445

Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients

NCT00002445 ↗

Phase 3 Completed 200 enrolled Cytran

Double-blindTreatment

Summary

The purpose of this study is to see if it is safe and effective to use IM862 to treat Kaposi's sarcoma (KS) in AIDS patients.

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	oglufanide	Small molecule	—	Intranasal

Indications